Chang LW, Wang SS, Yang CK, Lu K, et al. Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia. Anticancer Res 2023;43:485-491.
PMID: 36585197